Mergers & Acquisitions

Actavis to Acquire Durata Therapeutics, Inc.

Actavis to Acquire Durata Therapeutics, Inc. – Lead Product DALVANCE™ a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings – – Enhances Actavis’ Long-term Growth Profile 2015+ – – Experienced Development and Commercial Team Bolsters Actavis’ Infectious Disease Expertise – – Leverages Actavis’ Hospital Sales and Marketing Capabilities – PR Newswire DUBLIN, Ireland and CHICAGO, Oct. […]

Mergers & Acquisitions

Salo expands in the windy city

Salo expands in the windy city Acquisition of Chicago business increases Salo’s presence PR Newswire MINNEAPOLIS/CHICAGO, Oct. 6, 2014 MINNEAPOLIS / CHICAGO , Oct. 6, 2014 /PRNewswire/ — Salo announced today the acquisition of the Chicago -based business formerly known as The Johnsson Group from PRGX Global, Inc., the world’s leading provider of accounts payable recovery audit services […]

Mergers & Acquisitions

DEKRA Acquires Rail Testing Institute Plurel

DEKRA Acquires Rail Testing Institute Plurel PR Newswire STUTTGART, Germany, October 6, 2014 STUTTGART, Germany , October 6, 2014 /PRNewswire/ — DEKRA expands in the rail transport industry The DEKRA Rail division has been bolstered by the leading testing institute for rail transport in the Benelux countries. DEKRA is acquiring all shares in Plurel B.V. […]

Momentum Stocks

Bear of the Day: Bloomin’ Brands (BLMN) – Bear of the Day

It has been a very rough stretch for the restaurant industry as a number of issues have conspired to drag down many names in the space. First, it was wild weather that kept many customers at home, but then sluggish economic conditions and broad investor concerns about heavy competition and changing consumer tastes acted as the next catalyst to send stocks lower in this industry. […]

Mergers & Acquisitions

BD To Acquire CareFusion For $12.2 Billion

BD To Acquire CareFusion For $12.2 Billion Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions Accelerates BD’s Strategy to Improve Quality of Care and Reduce Healthcare Costs; Enhances Emerging Market Growth Opportunities Generates Significant Value for Shareholders; Accretive to Cash EPS on a Double-Digit Percentage Basis in the First Full Year PR Newswire FRANKLIN LAKES, N.J. and SAN DIEGO, Oct. 5, 2014 FRANKLIN LAKES, N.J. […]

Max Keiser

Keiser Report: Financial Ebola (E662)

[youtube UqtrhhbzNRc] In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss life imitating art as markets, economies and populations transforming into Kafkaesque giant vermin unrecognisable to the men and women we once were. Whether the man zombified by his iPad or the income distribution pie chart grotesquely distorted, some have grown used to this new ugly reality; whilst others wish the system will die so progress can return. […]

Max Keiser

Keiser Report: Financial Ebola (E622)

[youtube UqtrhhbzNRc] In this episode of the Keiser Report, Max Keiser and Stacy Herbert discuss life imitating art as markets, economies and populations transforming into Kafkaesque giant vermin unrecognisable to the men and women we once were. Whether the man zombified by his iPad or the income distribution pie chart grotesquely distorted, some have grown used to this new ugly reality; whilst others wish the system will die so progress can return. In the second half, Max interviews John Perkins, author of Confessions of an Economic Hitman, about ‘peak bankster.’ They also discuss IMF debt swiftly following on coups around the world. […]

Stock Analysts

MannKind Receives $150 Million Upfront Payment from Sanofi

MannKind Corporation ( MNKD ) has been in search of a suitable partner ever since the FDA cleared Afrezza inhalation powder for the improvement of glycemic control in adults suffering from diabetes mellitus in Jun 2014. The search finally came to an end in Aug 2014, when the company announced a worldwide agreement with Sanofi ( SNY ) on Afrezza (read: MannKind Enters into a Global Deal with Sanofi for Afrezza ). Earlier in the week, MannKind received an upfront payment of $150 million related to the agreement from Sanofi. […]